Company Number: 12708154

Analysis Date: 2025-07-29 20:44 UTC

Financial Health Assessment for Alexon Ltd as of 30 June 2024

---

1. Financial Health Score: D

Explanation:
The company shows significant financial distress with worsening net liabilities over recent years. The negative net assets and working capital, alongside a director’s loan accounting for most liabilities, indicate a fragile financial state that requires urgent remedial actions.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Fixed Assets	£444	Minimal long-term assets, showing low capital investment.
Current Assets (including Cash)	£1,018	Very low liquid assets, indicating poor cash reserves.
Current Liabilities	£64,862	High short-term obligations, largely due to director’s loan.
Net Current Assets (Working Capital)	-£63,844	Strong negative working capital, a symptom of liquidity distress and inability to meet short-term debts.
Net Assets (Shareholders' funds)	-£63,488	Negative equity signals insolvency risk if not addressed.
Share Capital	£1	Minimal equity capital, insufficient to buffer losses.
Director’s Loan Account	£64,462	Director financing the company, indicating reliance on related party funds instead of external funding.

---

3. Diagnosis: Financial Condition

Alexon Ltd is exhibiting symptoms akin to a patient with critical liquidity and solvency issues. The company’s negative net assets and deeply negative working capital suggest it is "underweight" financially and struggling to stay afloat without significant support. The increasing magnitude of director’s loans signals dependency on internal funding rather than generating operational cash flow or securing external financing.

The absence of turnover or profitability data in the accounts narrative and no employees suggest the company may be inactive operationally or in a start-up phase with limited trading activity. Despite being active, the business appears "ill" financially, with liabilities far exceeding assets.

The company has not been audited but has complied with filing requirements, which points to administrative health but does not alleviate financial risks.

---

4. Recommendations: Treatment Plan for Financial Wellness

• Improve Liquidity: Seek to convert any receivables or assets into cash promptly to relieve pressure on current liabilities. If operations are dormant, consider winding down non-essential expenses.
• Debt Restructuring: Engage with the director and any creditors to restructure the director’s loan or convert some debt into equity to improve the balance sheet.
• Capital Injection: Consider raising additional equity capital to strengthen shareholders’ funds and reduce dependency on director loans.
• Operational Review: If trading, focus on increasing revenue streams and controlling costs to generate positive cash flow and reverse the negative working capital trend.
• Financial Monitoring: Implement regular cash flow forecasting and budgeting to detect early signs of distress and manage expenses proactively.
• Professional Advice: Given the severity of financial distress, consultation with insolvency practitioners or financial advisors may be prudent to explore turnaround options or formal restructuring.

---

Medical Analogy Summary:

Alexon Ltd exhibits "symptoms of severe financial distress" characterized by "negative equity" and "critical liquidity deficiency." The company’s "financial heart" is struggling to pump sufficient cash to meet its short-term obligations, relying heavily on director loans, akin to a patient dependent on external life support. Immediate "treatment" involving restructuring, capital infusion, and operational improvements are recommended to restore financial health and prevent "collapse."

---